Evidence map›Paper›PMID 42009806›Full record

ArticleGene therapy2026

Correction: Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications.

Stefano Cattaneo, Barbara Bettegazzi, Selene Ingusci, Gianluca Verlengia, Anna Sofia Tascini, Silvia Zucchini, Franca Codazzi, Marco J Morelli, Marco Marzulli, Joseph C Glorioso and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Gene therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Stefano CattaneoVita-Salute San Raffaele University, Milan, Italy.
Barbara BettegazziVita-Salute San Raffaele University, Milan, Italy. bettegazzi.barbara@hsr.it.ORCID http://orcid.org/0000-0001-5842-105X
Selene IngusciDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-8534-5942
Gianluca VerlengiaDivision of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Anna Sofia TasciniVita-Salute San Raffaele University, Milan, Italy.ORCID http://orcid.org/0000-0001-5731-5490
Silvia ZucchiniDepartment of Neuroscience and Rehabilitation, Section of Pharmacology, University of Ferrara, Ferrara, Italy.
Franca CodazziVita-Salute San Raffaele University, Milan, Italy.
Marco J MorelliCenter for Omics Sciences COSR, BioInformatics Laboratory, San Raffaele Scientific Institute, Milan, Italy.
Marco MarzulliDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Joseph C GloriosoDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-1818-2645
Michele SimonatoDivision of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42009806
PMCPMC13585558

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.